ArticleCancer immunology, immunotherapy : CII2025

Prostaglandin F2 receptor negative regulator as a potential target for chimeric antigen receptor-T cell therapy for glioblastoma.

Hideki Kuroda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.